ArticleJournal of thoracic disease2026
The safety and feasibility of non-intubated versus intubated video-assisted thoracic surgery in NSCLC patients after neoadjuvant therapy: a propensity score matching study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is the leading cause of cancer-related death worldwide, with non-small cell lung cancer (NSCLC) accounting for over 85% of cases. Surgical resection is the main treatment for early-stage NSCLC, and neoadjuvant therapy is widely used for locally advanced or high-risk patients to improve resectability and survival. Video-assisted thoracoscopic surgery (VATS) has become the standard minimally invasive approach. With the development of enhanced recovery after surgery protocols, non-intubated VATS (NI-VATS) has shown advantages in reducing airway injury, postoperative complications, and accelerating recovery. However, the safety of NI-VATS in patients receiving neoadjuvant therapy remains unclear. Neoadjuvant therapy may cause tissue fibrosis and adhesions, and the unstable surgical field of NI-VATS increases surgical concerns. Relevant evidence is still limited. This study aims to explore the safety and feasibility of NI-VATS in NSCLC patients after neoadjuvant therapy, and to compare the safety and feasibility of NI-VATS versus intubated video-assisted thoracic surgery (I-VATS) in patients with NSCLC after neoadjuvant therapy. Methods: The clinical data of 181 NSCLC patients who underwent surgical treatment after neoadjuvant therapy in the Affiliated Hospital of Hebei University from June 2022 to December 2024 were retrospectively analyzed. Patients were divided into the NI-VATS group (n=36) and the I-VATS group (n=145) by anesthesia method. After 1:1 propensity score matching (PSM), 31 pairs of balanced baseline data were selected to compare the perioperative outcomes. Results: After PSM, the baselines of the two groups of patients were balanced. Operative time, intraoperative blood loss, lymph node (group and number), R0 resection rates, and postoperative drainage volumes were similar between groups (P>0.05). The NI-VATS group demonstrated significantly shorter anesthesia auxiliary airway removal time (12.32±10.46 Conclusions: For NSCLC patients after neoadjuvant therapy, NI-VATS is a safe, feasible and effective surgical method. It significantly enhances postoperative recovery, reducing complications and resource utilization, aligning well with enhanced recovery after surgery (ERAS) principles. It is worthy of further necessary research and promotion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.